UNIVERSITY OF SOUTH FLORIDA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1956-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.usf.edu
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2012-06-18
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 20
- Registration Number
- NCT00992771
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸University of California - Los Angeles, Los Angeles, California, United States
Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2014-04-02
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 9
- Registration Number
- NCT00949117
Strategies To Prevent Pneumonia 2 (SToPP2)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-06
- Last Posted Date
- 2016-01-11
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 314
- Registration Number
- NCT00893763
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-15
- Last Posted Date
- 2015-06-11
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 31
- Registration Number
- NCT00881465
- Locations
- 🇺🇸
University of South Florida, St. Petersburg, Florida, United States
Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- University of South Florida
- Registration Number
- NCT00880386
Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 20
- Registration Number
- NCT00879879
- Locations
- 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States
D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2012-10-17
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 30
- Registration Number
- NCT00864123
- Locations
- 🇺🇸
University of South Florida, St. Petersburg, Florida, United States
Reduction of Endometritis After Cesarean Section With the Routine Use of Methergine
- First Posted Date
- 2009-03-10
- Last Posted Date
- 2012-09-19
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 44
- Registration Number
- NCT00858832
- Locations
- 🇺🇸
Tampa General Hospital, Tampa, Florida, United States
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
- First Posted Date
- 2008-12-08
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 28
- Registration Number
- NCT00803868
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Keppra for Cervical Dystonia
Phase 2
Terminated
- Conditions
- First Posted Date
- 2008-09-26
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 17
- Registration Number
- NCT00760318
© Copyright 2024. All Rights Reserved by MedPath